Variable | Likelihood Ratio | P Value |
Ambulation at discharge | ||
Agea | - | 0.814 |
BMIa | - | 0.945 |
Sex | 0.01 | 0.907 |
CAD | 0.22 | 0.636 |
CHF | 1.24 | 0.266 |
COPD | 0.19 | 0.662 |
DM | 0.30 | 0.583 |
HTN | 1.80 | 0.180 |
Prior fusion | 4.01 | 0.045b |
Anticoagulation | 1.26 | 0.245 |
ASA >3 | 3.93 | 0.048b |
Fracture location | 0.04 | 0.834 |
Approach | 0.69 | 0.406 |
30-d mortality | ||
Agea | - | 0.508 |
BMIa | - | 0.955 |
Sex | 0.00 | 1.000 |
CAD | 0.07 | 0.739 |
CHF | 0.04 | 0.852 |
COPD | 0.04 | 0.836 |
DM | 0.27 | 0.602 |
HTN | 2.53 | 0.112 |
Prior fusion | 1.94 | 0.164 |
Anticoagulation | 1.57 | 0.210 |
ASA >3 | 0.07 | 0.786 |
Fracture location | 0.17 | 0.679 |
Approach | 0.19 | 0.664 |
↵a Age and BMI we calculated with t test vs χ 2 test.
↵b Indicates significance level <0.05.
ASA, American Society of Anesthesiologists; BMI, body mass index; CAD, coronary artery disease; CHF, congestive heart failure ; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; HTN, hypertension.